US Broker Ratings

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth Challenges in the Healthcare Sector

Mettler-Toledo International, Inc. (MTD), a stalwart in the Diagnostics & Research industry, operates under the Healthcare sector with an impressive market presence across the Americas, Europe, Asia, and beyond. With..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a 2.97% Potential Upside with Strong Buy Ratings

HCA Healthcare, Inc. (HCA) stands as a significant player within the healthcare sector, particularly in the medical care facilities industry in the United States. With a robust market capitalization of..

STERIS plc (STE) Stock Analysis: A Glimpse into Healthcare Growth and a 10.76% Potential Upside

Investors with an eye on the healthcare sector might want to take a closer look at STERIS plc (NYSE: STE), a dominant player in the medical devices industry. With a..

The Cigna Group (CI) Stock Analysis: Robust Revenue Growth with a 17% Potential Upside

The Cigna Group (NYSE: CI), a titan in the healthcare sector with a market cap of $85.42 billion, continues to capture investor interest with its expansive portfolio of health insurance..

Abbott Laboratories (ABT) Stock Analysis: Growth Potential and a Solid Dividend Offering

Abbott Laboratories (NYSE: ABT) stands as a stalwart in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $233.9 billion, Abbott is a significant player..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 29% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $162.07 billion, the company..

CVS Health Corporation (CVS) Stock Analysis: Assessing an 18% Upside Potential with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, is capturing investor attention with its robust market position and a potential upside of 18.24% as per analyst..

Edwards Lifesciences Corporation (EW) Stock Analysis: Evaluating Growth and Investor Sentiment in the Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector specializing in medical devices for cardiovascular diseases, commands a significant market capitalization of $45.05 billion. Headquartered in Irvine,..

AstraZeneca PLC (AZN) Stock Analysis: Examining a Potential 21% Upside for Savvy Investors

AstraZeneca PLC (AZN), a stalwart in the global healthcare sector, remains an attractive proposition for investors, with a substantial market cap of $215.91 billion. Headquartered in Cambridge, United Kingdom, AstraZeneca..

Bristol-Myers Squibb (BMY) Investor Outlook: Analyzing a 21.69% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, commands significant attention with its robust portfolio of biopharmaceutical products. With a market capitalization of $95.49 billion, this U.S.-based..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Evaluating a Potential 35.99% Upside in a Volatile Market

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector specializing in molecular diagnostics and precision medicine, presents a fascinating opportunity for investors navigating a volatile market. With..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Biotech with a 277.40% Upside Potential

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company situated in Dublin, Ireland, is garnering significant attention in the healthcare sector. Specializing in developing therapies for diseases caused by protein dysregulation,..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Strategic Innovation in Medical Devices

Surmodics, Inc. (NASDAQ: SRDX), a prominent player in the healthcare sector, is making strategic strides within the medical device industry. Headquartered in Eden Prairie, Minnesota, the company is known for..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a 113% Potential Upside in the Biotech Sector

Septerna, Inc. (NASDAQ: SEPN) has been capturing the attention of investors with its significant upside potential, as reflected in the 113.28% potential gain suggested by the current analyst ratings. This..

Verve Therapeutics, Inc. (VERV) Growth Potential: A 33.93% Upside in the Gene Editing Arena

Verve Therapeutics, Inc. (NASDAQ: VERV), a trailblazer in the biotechnology sector, is carving a niche in the healthcare landscape with its innovative approach to treating cardiovascular disease through gene editing...

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Exploring a 122.94% Potential Upside in Biotech

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is carving a niche in the biotechnology sector with its focus on addressing unmet medical needs for rare diseases. As a commercial-stage company, Zevra has..

PureTech Health plc (PRTC) Stock Analysis: Unveiling a 195% Potential Upside

PureTech Health plc (LSE: PRTC), a prominent player in the biotechnology sector, is capturing attention with its impressive potential upside, making it an intriguing prospect for investors seeking opportunities in..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Uncovering a Potential 190% Upside in the Biotechnology Sector

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a burgeoning force in the biotechnology sector, has caught the attention of investors with its promising potential upside of 190.70%. This clinical-stage biopharmaceutical company, headquartered..

Valneva SE (VALN) Stock Analysis: Exploring the 130% Upside Potential in the Biotech Sector

Valneva SE (NASDAQ: VALN), a French-based biotechnology company, is making waves in the healthcare sector with its innovative vaccine offerings targeting infectious diseases with unmet needs. With a current market..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 54% Potential Upside in the Biotech Arena

Theravance Biopharma, Inc. (NASDAQ: TBPH), a notable player in the biotechnology sector, is making waves with its promising pipeline and strategic collaborations. For investors with a keen eye on the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds